No Detail Found!

Response of plasmodium vivax malaria induced thrombocytopenia to antimalarial treatment

Author(s)
Abdul Latif Khattak Department of Medicine, Combined Military Hospital (CMH) Sialkot, Pakistan
Waqar Ali Department of Pathology, CMH,Murree, Rawalpindi, Pakistan
Naseer Ahmed Khan Department of Medicine, CMH, Rawalpindi, Pakistan
Luqman Satti Department of Pathology, CMH, Dera Ismail Khan, KPK, Pakistan
Muhammad Idris Department of Pathology, Ayub Medical College, Abbottabad, Pakistan
Abstract
Background: Thrombocytopenia is often seen in the patients of malaria infected with Plasmodium vivax. We studied patients admitted in hospital having coexisting thrombocytopenia and malaria, and recorded the response to anti-malarial therapy. Methods: In this cross-sectional descriptive study, a total of 120 patients admitted in medical ward with Plasmodium vivax malaria and co-existing thrombocytopenia were studied. Results: Out of total 120 slide positive Malaria patients who had low platelet count (<150×109 /L), platelet count increased to =150×109 /L in 73 (60.8%) patients after five days of anti-malarial therapy while in 47 (39.2%) patients thrombocytopenia persisted. After ten days of anti-malarial therapy, platelet count in all the patients recovered to =150×109 /L. None of the patients required platelet transfusion. Conclusion: In majority of the patients of Plasmodium vivax malaria having thrombocytopenia, platelet count returns to normal within five to ten days of start of anti-malarial treatment and platelet transfusion is not required.
Publication Details
Page(s) 463-465
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 26, Issue: 4, Year: 2014

Request the full text from PASTIC

Keywords
Plasmodium vivax, thrombocytopenia, Malaria, Chloroquine, Malaria
0

Citations

0

Downloads

57

Views